| Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. (NCT05425745) | NewAmsterdam Pharma | 2022-07-25 |
| Effects of Dengzhanxixin Capsule on Platelet Function in Individuals at High Risk for Cardiovascular Disease (NCT05459519) | China National Center for Cardiovascular Diseases | 2022-07-20 |
| A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease (NCT05398029) | Verve Therapeutics, Inc. | 2022-07-05 |
| Effects of Chios Mastiha Essential Oil on Cholesterol Levels of Healthy Volunteers (NCT05858372) | AHEPA University Hospital | 2022-07-01 |
| A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy. (NCT05421078) | NewAmsterdam Pharma | 2022-06-27 |
| Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients (NCT05004675) | LIB Therapeutics LLC | 2022-06-20 |
| Screening for Hypercholesterolemia in Children Using Dried Blood Spot (NCT05191355) | Hospices Civils de Lyon | 2022-05-18 |
| The Impact of Chokeberry Bioproducts on Metabolic Parameters and Antioxidant Potential (NCT06435130) | Medical University of Bialystok | 2022-05-01 |
| SurveY Followed by a Retrospective Chart Review to Describe the Key Factors Leading to Physician's Decision to Treat Patients at High and Very High Cardiovascular Risk With hyperchOlesterolemia or Mixed Dyslipidemia With NUSTENDI® (NCT05546398) | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 2022-04-22 |
| Clinical Trials of Five Different Food Supplements With Restriction Diet in Adults (NCT05333315) | University of Primorska | 2022-04-20 |
| Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia (NCT05192941) | Novartis Pharmaceuticals | 2022-04-08 |
| Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic Inflammation (NCT06247137) | University of Bologna | 2022-04-01 |
| A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008) (NCT05261126) | Merck Sharp & Dohme LLC | 2022-03-10 |
| Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy (NCT05266586) | NewAmsterdam Pharma | 2022-03-09 |
| Effects of a Chilean Diet Supplemented With Gevuina Avellana on Lipid Profile in Humans With Hypercholesterolemia (NCT07087704) | Universidad de Concepcion | 2022-03-08 |
| Independent Effects of High-cholesterol (High-egg) and High-saturated Fat Diets on LDL-cholesterol (NCT05267522) | University of South Australia | 2022-03-01 |
| Metabolic Effect of an Innovative Chitosan Formulation (NCT05188430) | University of Bologna | 2022-03-01 |
| A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting (NCT05362903) | Novartis Pharmaceuticals | 2022-01-31 |
| Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product (NCT05234775) | LIB Therapeutics LLC | 2022-01-28 |
| Investigating the Dose Response of an Almond-enriched Diet on Optimizing HDL-C in a Population With Hypercholesterolemia (NCT05174663) | Almond Board of California | 2022-01-10 |
| Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia (NCT07445542) | JW Pharmaceutical | 2021-12-18 |
| Effect of Oleactiv® on LDL Oxidability (NCT05221346) | Institut Pasteur de Lille | 2021-12-13 |
| The Effect of Progressive Resistance Exercise Training (PRET) on CVRF in Adults With ID. (NCT06579898) | Erasmus Medical Center | 2021-12-01 |
| Diet-induced Elevations in LDL-C and Progression of Atherosclerosis (NCT05733325) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2021-10-18 |
| Diet and Plant Sterols in the Control of Cholesterolemia (DESCO) (NCT05265455) | University of Bologna | 2021-10-01 |
| Role of A2A Receptor in Hypercholesterolemic Patients (NCT05017649) | Assistance Publique Hopitaux De Marseille | 2021-09-20 |
| Lipid Lowering Effect of Plant Stanol Ester in a Drinkable Non-dairy Product (NCT05126056) | Raisio Group | 2021-09-01 |
| Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia (NCT04929457) | Karolinska Institutet | 2021-09-01 |
| A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older (NCT07489183) | Dong Wha Pharmaceutical Co. Ltd. | 2021-08-23 |
| Lipid Lowering Effect of Plant Stanol Ester in a Spoonable Non-dairy Product (NCT05064644) | Raisio Group | 2021-08-01 |
| Baromètre Santé Adulte 2021-2022 (NCT05218304) | Agence Sanitaire et Sociale de Nouvelle Calédonie | 2021-07-26 |
| Onco-primary Care Networking to Support TEAM-based Care (NCT04258813) | Duke University | 2021-06-14 |
| Cholesterol Lowering Effect of Cardio-Complement, an Ayurveda Formulation (NCT04974853) | NMP Medical Research Institute | 2021-06-01 |
| Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old (NCT04897113) | National Medical Research Center for Rehabilitation and Balneology | 2021-05-12 |
| Clinical Trials of Two Helichrysum Infusions in Adults (NCT04866628) | University of Primorska | 2021-05-06 |
| Investigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults (NCT04783714) | Swisse Wellness Pty Ltd | 2021-04-30 |
| Supplements, Placebo, or Rosuvastatin Study (NCT04846231) | The Cleveland Clinic | 2021-04-23 |
| Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction (NCT04806893) | LIB Therapeutics LLC | 2021-04-22 |
| Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients (NCT04790513) | LIB Therapeutics LLC | 2021-04-22 |
| Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic (NCT04927221) | Guangzhou JOYO Pharma Co., Ltd | 2021-04-01 |
| A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia (NCT04784442) | Otsuka Pharmaceutical Co., Ltd. | 2021-03-24 |
| Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C) (NCT04765657) | Novartis Pharmaceuticals | 2021-03-01 |
| Randomized Study of Obicetrapib in Combination With Ezetimibe (NCT04770389) | NewAmsterdam Pharma | 2021-02-23 |
| Randomized Study of Obicetrapib as an Adjunct to Statin Therapy (NCT04753606) | NewAmsterdam Pharma | 2021-02-18 |
| Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects (NCT04760951) | Valbiotis | 2021-02-17 |
| A Study of IBI306 in Participants With Hypercholesterolemia (NCT04709536) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-02-09 |
| Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C (NCT04666298) | Novartis Pharmaceuticals | 2021-01-29 |
| Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia (NCT04579367) | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 2021-01-15 |
| PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health (NCT04673721) | Duke University | 2021-01-06 |
| Hypocholesterolemic Effect of a Phytosterol-enriched Spreadable Cream Prepared With Virgin Olive Oil (NCT05460208) | Universidad de Granada | 2021-01-01 |
| Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical (NCT05000541) | Mylan Inc. | 2020-12-08 |
| A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy (NCT04669041) | Sanofi | 2020-12-08 |
| Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia (NCT04659525) | Policlinico Casilino ASL RMB | 2020-11-01 |
| Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia (NCT04485793) | University of Bologna | 2020-09-21 |
| Food Supplementation With Eufortyn Colesterolo Plus for LDL Modulation in Subjects With Polygenic Hypercholesterolemia (NCT04574505) | University of Bologna | 2020-09-14 |
| Nutritional Intervention With Black Garlic (NCT05082350) | Maria Pilar Zafrilla Rentero | 2020-09-01 |
| Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion (NCT04314167) | University Hospital Tuebingen | 2020-07-28 |
| Kefir Cholesterol Lowering Pilot Study (NCT04247139) | University of Alberta | 2020-07-07 |
| Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia (NCT06293261) | Yuhan Corporation | 2020-06-27 |
| Effects of Atorvastatin in Graves' Orbitopathy (GO) (NCT03110848) | University of Pisa | 2020-06-01 |
| A Study of PCSK9 Inhibitor AK102 in Patients With Hypercholesterolemia (NCT04358432) | Akeso | 2020-05-13 |
| Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients (NCT04397653) | Policlinico Casilino ASL RMB | 2020-05-04 |
| HealthMatters@24/7 eLearning for People Supporting Adults With Intellectual and Developmental Disabilities (NCT03206164) | University of Illinois at Chicago | 2020-05-01 |
| Safety and Efficacy of IBI306 in Chinese Subjects With Non-familial Hypercholesterolemia (NCT04289285) | Innovent Biologics (Suzhou) Co. Ltd. | 2020-04-29 |
| Effect of Atorvastatin on Carotid Intima Media Thickness (NCT04306627) | Yerevan State Medical University | 2020-04-15 |
| K-924 Phase III Confirmatory Study (NCT04289649) | Kowa Company, Ltd. | 2020-04-02 |
| K-924 Phase III Long Term Study (NCT04289662) | Kowa Company, Ltd. | 2020-03-23 |
| Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events (NCT04271280) | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 2020-03-17 |
| Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy (NCT05430828) | Federico II University | 2020-03-07 |
| Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors (NCT04319081) | Jose Seijas Amigo | 2020-03-01 |
| Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine (NCT04158076) | Addpharma Inc. | 2020-01-23 |
| Supplementation of Oil Palm Phenolics to Healthy Participants (NCT04164446) | National University of Malaysia | 2019-12-16 |
| Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study (NCT04536870) | Monash University | 2019-12-12 |
| Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy (NCT04164888) | Civi Biopharma, Inc. | 2019-11-11 |
| A Long-term Study of AK102 in Patients With Hypercholesterolemia (NCT04173403) | Akeso | 2019-11-04 |
| Evaluating the Efficacy of Pediatric Lipid Screening Alerts (NCT04118348) | Geisinger Clinic | 2019-10-10 |
| Health Effects of Consuming Olive Pomace Oil (NCT04998695) | Instituto de Ciencia y Tecnología de Alimentos y Nutrición | 2019-09-09 |
| Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439) (NCT03768427) | Organon and Co | 2019-05-27 |
| Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI (NCT03718286) | Population Health Research Institute | 2019-03-11 |
| Effect of Canned Beans of Multiple Varieties in Daily Amounts of 1 Cup and 1/2 Cup on Serum LDL Cholesterol and Other Cardiovascular Disease Risk Biomarkers in Adults With Elevated LDL Cholesterol (NCT03830970) | University of Guelph | 2019-03-05 |
| Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan (NCT03872232) | Addpharma Inc. | 2019-02-26 |
| Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003 (NCT03847974) | LIB Therapeutics LLC | 2019-02-14 |
| CoQ10 in Statin-associated Asthenia (NCT06391606) | University of Bologna | 2018-10-01 |
| Translation of Pritikin Program to the Community (NCT03929198) | Washington University School of Medicine | 2018-09-27 |
| The Effect of Viscous Dietary Fibers on LDL-cholesterol (NCT04133805) | Unity Health Toronto | 2018-09-17 |
| Diets Enriched With Pecans (NCT04376632) | University of Georgia | 2018-08-10 |
| Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients (NCT03611010) | Cumberland Pharmaceuticals | 2018-08-07 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels. (NCT03593785) | AstraZeneca | 2018-08-03 |
| Safety and Efficacy of Propionate for Reduction of LDL Cholesterol (NCT03590496) | Charite University, Berlin, Germany | 2018-07-25 |
| Low Versus High-glycemic Index Post-exercise Diets for Improving Metabolism and Body Composition (NCT03587051) | University of Saskatchewan | 2018-07-15 |
| The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment (NCT04270344) | JW Pharmaceutical | 2018-07-01 |
| Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia (NCT03559309) | Medical University of Graz | 2018-06-20 |
| Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population (NCT03543774) | Hue University of Medicine and Pharmacy | 2018-06-15 |
| Effect of Indian Gooseberry Extract (AMX160) in Hypercholesterolemia (NCT03479983) | Arjuna Natural Limited | 2018-06-04 |
| Oil Consumption and Cholesterol (NCT04397055) | University of Georgia | 2018-05-14 |
| Alirocumab in Patients on a Stable Dialysis Regimen (NCT03480568) | Baylor Research Institute | 2018-05-01 |
| A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia (NCT03381287) | HighTide Therapeutics (Hong Kong) Limited | 2018-04-13 |
| Health Effects of Consuming Olive Pomace Oil (NCT04997122) | Instituto de Ciencia y Tecnología de Alimentos y Nutrición | 2018-04-02 |
| Detection and Treatment of Somatic Disease in Patients With Severe Mental Disease (NCT03428308) | Intersectoral Research Unit for Health Services | 2018-04-01 |
| Interplay Between Adherence to the Mediterranean Diet, Lipid Profile and Blood Pressure: a Comparative Survey Among Healthcare and Non-Healthcare Female Workers (NCT04596358) | University of Bari Aldo Moro | 2018-03-10 |